Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

3 Penny Stocks That Will Be the Surefire AI Winners of Tomorrow 

AI penny stocks carry substantial risk, but also offer the potential for massive upside; here are three stocks for your 2024 watchlist

AI Ascending: 3 Under-the-Radar Tech Stocks Poised for Explosive Growth

Here are three tech stocks for investors looking to speculate in the growth of AI with stocks that have a lower valuation.

The 3 Most Undervalued Stocks Under $20 to Buy in January

Stocks are looking a little pricey again which makes this a good time to look for value, especially undervalued stocks under $20.

Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends 

Here are seven overlooked high-yield dividend stocks for you to consider no matter where interest rates at the end of 2024.